Abiopharma

(99% Neutral) BIOATLA, INC. (BCAB) Announces Executive Changes

(10% Negative) Adicet Bio, Inc. (ACET) Announces Clinical Trial Timeline Adjustment

(99% Neutral) IONIS PHARMACEUTICALS, INC. (IONS) Announces Regulatory Update

(99% Neutral) PMV Pharmaceuticals, Inc. (PMVP) Announces Regulatory Update

(99% Neutral) SAB BIOTHERAPEUTICS, INC. (SABS) Provides Update on patients for all phases of global clinical development

(10% Negative) Cyteir Therapeutics, Inc. (CYT) Announces Delay in well Trials for advanced Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Manufacturing Considerations, Safety Review, Efficacy Assessment

(92% Neutral) Mirum Pharmaceuticals, Inc. (MIRM) Provides Update on directors for Day One Biopharmaceuticals

(99% Neutral) Imago BioSciences, Inc. (IMGO) Files Form 8-K

(70% Positive) MIRATI THERAPEUTICS, INC. (MRTX) Announces Clinical Development Update

(80% Positive) Global Blood Therapeutics, Inc. (GBT) Announces Enrollment Update for options Due to Pandemic-Related Challenges, Patient Enrollment Issues, Regulatory Process, Safety Review, Efficacy Assessment